Core Points - The forum titled "Integration of Industry, Academia, and Research on Classic Chinese Medicine Formulas" was held in Zhuhai, focusing on the internationalization of traditional Chinese medicine (TCM) [1][3] - The project "Pharmacological Verification and Formulation Optimization of Classic Formulas Huangqi Guizhi Wuwu Decoction and Taohong Siwu Decoction" was officially launched during the forum [1][21] - The event was co-hosted by the Macau University of Science and Technology and Beijing Tongrentang Group, highlighting the collaboration between academia and industry [1][3] Industry Development - The forum aimed to promote the industrialization and academic research of classic TCM formulas, facilitating cross-border exchanges [1][3] - Experts discussed the current state of the TCM industry and the development practices of classic formulas, providing strategies for modernization and internationalization [9][13] - The project received funding of over 12 million Macanese Patacas from the Macao SAR government, indicating strong governmental support for TCM development [21] Collaboration and Future Prospects - The collaboration between Macau University of Science and Technology and Tongrentang Group is seen as a significant step towards modernizing and internationalizing TCM [5][28] - The forum included discussions on the advantages of the Hong Kong-Macao TCM industry and the role of modern technology in TCM research [24][26] - Future efforts will focus on enhancing the international influence of the Tongrentang brand and expanding its market presence globally [7][28]

Group 1 - A group of 21 foreign students from countries such as Portugal, Brazil, and Ireland is studying traditional Chinese medicine in Sanya, Hainan Province [2] - The first Traditional Chinese Medicine Cultural Night Market opened in Shawan City, Xinjiang, featuring medical talents providing services and free health food for citizens [4] - In Nanning, Guangxi, citizens are utilizing traditional therapies like "Sanfu Ties" to enhance their resistance against illnesses during the summer [8] Group 2 - The National Administration of Traditional Chinese Medicine held a press conference discussing health preservation methods through traditional Chinese medicine during the summer [8] - Experts emphasize the importance of preventing heatstroke and sunburn during high temperatures, recommending avoiding outdoor activities during peak UV hours [9][10] - Dietary recommendations include consuming warm beverages instead of cold drinks and focusing on seasonal fruits and vegetables to maintain digestive health [11][12][13] Group 3 - Exercise recommendations suggest engaging in light activities during cooler parts of the day, such as Tai Chi and Baduanjin, to promote health without overexertion [14][15] - For travelers, it is advised to gradually adapt to local foods and maintain hydration to prevent gastrointestinal issues [17][18]

Core Insights - Guangzhou has been selected as one of the 15 cities for the national demonstration project supported by central financial funding for the inheritance and innovation of traditional Chinese medicine (TCM) [1] - The project aims to promote the inheritance and innovation of TCM techniques, talent cultivation, service models, and management system innovations, creating replicable and promotable experiences [1] Group 1: Project Objectives - The project is jointly promoted by the Ministry of Finance and the National Administration of Traditional Chinese Medicine [1] - It aims to establish a national-level demonstration benchmark for TCM development [1] Group 2: Implementation Strategies - Guangzhou will implement three major projects for the inheritance of Lingnan TCM techniques, three specialized projects for TCM scientific research innovation, and three levels of talent team construction [1] - The city plans to innovate four service models and establish five mechanisms for TCM management system innovation [1] - Five major actions will be taken to build the Yangcheng TCM cultural brand [1] Group 3: Expected Outcomes - The initiative aims to create demonstration benchmarks in six areas: technical inheritance, industrial integration, talent teams, service models, mechanism reform, and cultural dissemination [1] - The goal is to develop a TCM model characterized by outstanding clinical efficacy, efficient scientific research transformation, intelligent service systems, and far-reaching cultural influence [1] - This project is expected to provide a replicable model for the high-quality development of TCM in the Guangdong-Hong Kong-Macao Greater Bay Area [1]

8月9日，2025年中草药囊泡研究与应用全球学术会议在广东省广州市举行。与会专家学者共同分享药用 植物囊泡的高水平研究成果，促进国内外合作，助力中医药传承创新以及现代化、国际化发展。 本次大会由中草药囊泡广东省工程研究中心、广东省中医药学会、广州中医药大学第三附属医院主办， 广州中医药大学第三附属医院医学检验科承办。 清华大学药学院教授、全球细胞外囊泡网络亚太区联络员尹航指出，细胞外囊泡作为一个细胞间通讯的 平台技术，为中医药产业升级提供了一个前所未有的机会。在全球细胞外囊泡蓬勃发展浪潮之下，我们 需要在法规、政策、原料供应等方面进行更多国际合作，力争让中草药细胞外囊泡为中药产业升级和国 际化开辟了新路径，让古老智慧与现代科技跨界融合。 （文章来源：科技日报） 南方医科大学基础医学院教授、广东省中医药学会中草药囊泡研究与应用专业委员会副主任委员樊俊兵 介绍，水果富含很多活性成分，包括维生素、矿物质、抗氧化剂等。果蔬囊泡在口服稳定性和生物相容 性上更有优势，未来在口服药物递送系统、功能性食品开发等领域应用前景广阔。 广州中医药大学第三附属医院医学检验科主任、中草药囊泡广东省工程研究中心主任、广东省中医药学 会中 ...

Core Insights - The report titled "Inheritance and Innovation: Decoding the Development Trajectory of Traditional Chinese Medicine (TCM) Science" highlights the rapid development and interdisciplinary integration of TCM research from 2014 to 2023 [1] Group 1: Research Growth - TCM research has seen participation from 188 countries and regions, with over 200,000 research papers published [1] - The compound annual growth rate (CAGR) of research quantity is 10.6%, significantly higher than the global average growth rate of 3.9% [1] - The total volume of related literature has nearly tripled, indicating a robust growth in the TCM research field [1] Group 2: Academic Impact - 14.2% of TCM literature ranks among the top 10% of the most cited papers globally, showcasing its academic influence [1] Group 3: Interdisciplinary Trends - 61.9% of TCM-related research falls within the medical field, while 33.1% pertains to biochemistry, genetics, and molecular biology, and 28.1% covers pharmacology, toxicology, and pharmacy [1] - This distribution reflects the trend of interdisciplinary collaboration and development in TCM research [1] Group 4: Institutional Contributions - Hong Kong Baptist University (HKBU) emphasizes the report as a significant achievement in promoting the standardization, modernization, and internationalization of TCM [1] - The report illustrates the extensive influence of TCM research in areas such as digital health and systems medicine [1] Group 5: Future Directions - The Vice President of HKBU suggests that TCM is moving towards a modern phase centered on systems medicine, integrating life sciences and data technology, which may establish new standards for the integration of Chinese and Western medicine [2]

Group 1 - The core point of the article is that Zhangzhou Pianzaihuang Pharmaceutical Co., Ltd. plans to invest 200 million RMB in the Gaoxin Runxin Fund, which represents 20% of the fund's target fundraising scale, aiming to enhance its competitive capabilities in the health industry [1] - The Gaoxin Runxin Fund focuses on the medical health sector, including pharmaceuticals, medical devices, and health-related products, with investments outside this sector not exceeding 10% of the total fund size [1] - Pianzaihuang has been actively seeking growth opportunities through investments and acquisitions to expand its business footprint in the health industry [1] Group 2 - Challenges faced by Pianzaihuang include heavy reliance on core products, insufficient diversification, and regional imbalances in brand channel construction [2] - The trend of traditional Chinese medicine companies investing in industry funds is accelerating, with around 40 listed companies participating in such investments since 2024, totaling 5 billion RMB [2] - Other companies like Guangzhou Baiyunshan Pharmaceutical Group and Yunnan Baiyao Group are also increasing their investments in industry funds to expand in the health and innovative drug sectors [2] Group 3 - Jiangzhong Pharmaceutical Co., Ltd. announced its plan to invest 40 million RMB in the Huaren Pharmaceutical Industry Investment Fund II, holding 4% of the fund's assets [3] - The investment strategy of these funds includes direct investments in pharmaceuticals, medical devices, and health services, aiming to accelerate the companies' presence in the biopharmaceutical and health sectors [3] - Industry funds led by major companies are expected to enhance the integration of the traditional Chinese medicine industry, increasing industry concentration through the synergy of policy, technology, and capital [3]

Core Viewpoint - Pianzaihuang Pharmaceutical is actively investing in the health industry by participating in the establishment of the Gao Xin Run Xin Fund, aiming to enhance its competitive edge and explore new growth opportunities within the health industry chain [1] Group 1: Investment Activities - Pianzaihuang plans to invest 200 million RMB in the Gao Xin Run Xin Fund, which represents 20% of the fund's target fundraising scale [1] - The Gao Xin Run Xin Fund is part of the "Yuan Shan Plan," a major industrial project initiated in April 2024 in Zhangzhou, focusing on creating a comprehensive ecosystem for traditional Chinese medicine [1] - The Zhangzhou government aims to establish a total of 5 billion RMB in health industry funds, with the Gao Xin Run Xin Fund being the third fund launched under this initiative [1] Group 2: Previous Fund Investments - In September 2024, Pianzaihuang announced a 200 million RMB investment in the Zhangzhou Yuan Shan Health Industry Investment Fund, holding a 40% stake in the first phase of the fund [2] - The Yuan Shan Fund has already achieved significant profits, with a reported investment return rate of 376% from acquiring a 5.02% stake in Guangsheng Tang, which has appreciated from 196 million RMB to a current market value of 932 million RMB [2] - In March 2025, Pianzaihuang also invested 200 million RMB in the Zhaoying Huikang Fund, which is managed by Zhaoshang Zhiyuan Capital and has a planned scale of 1 billion RMB [2] Group 3: Financial Performance - Pianzaihuang reported a revenue of 10.788 billion RMB in 2024, reflecting a year-on-year growth of 7.25%, and a net profit of 2.977 billion RMB, with a growth of 6.42% [2] - This marks the 15th consecutive year of revenue and net profit growth for Pianzaihuang, demonstrating its strong market competitiveness and resilience amid a slowing growth rate in the traditional Chinese medicine industry [2]

同时也要看到，推进改革仍面临不少难点堵点。中西医诊疗体系存在较大差异，中医辨证施治的灵活性 与西医标准化诊疗的规范性难以直接对标，导致疾病诊断、疗效评价等环节难以形成统一标准；部分中 医诊疗技术的个体化、经验化特性，与标准化定价机制存在冲突，技术劳务价值长期被低估，陷入定价 高低皆难的困境；改革涉及医保、卫健、中医药管理等多部门，协同推进难度不小，地方试点的成功经 验难以复制推广。这些问题的本质是中医药的独特属性与现有医疗管理体系的适配难题，可能出现"削 足适履"的政策偏差，亟需通过系统性改革加以破解。 深化中医医保支付方式改革，需要多维度协同发力、系统施策。在疗效评价上，应构建中西医双轨兼容 的体系，既保留西医客观量化指标，又纳入中医整体健康改善维度，让"同效"既有数据支撑，又能体现 中医药的深层价值。在定价机制上，要突破传统模式束缚，充分考量中医技术劳务价值，对整体治疗方 案实行打包定价，从根本上避免价值低估。医保支付要增强适配性，为中医优势病种单独分组，按中医 诊疗路径制定支付标准，建立动态调整机制，引导医疗机构优先选择成本低、效果好的中医方案。 协同推进还需强化部门联动与政策激励。要健全多部门协调机制 ...

Core Insights - The rise of "Traditional Chinese Medicine Night Markets" in Gansu Province reflects a growing interest in health and wellness among the public, particularly in urban areas [1][3][7] - The initiative is part of a broader cultural promotion campaign aimed at making traditional Chinese medicine more accessible and relatable to the general population [3][5][7] Group 1: Market Trends - "Traditional Chinese Medicine Night Markets" have become popular in bustling commercial areas, attracting crowds who seek relaxation and wellness treatments like acupuncture and moxibustion [1][3] - The markets offer a variety of experiences, including free herbal drinks and DIY activities for children, enhancing community engagement with traditional practices [3][5] Group 2: Consumer Behavior - Younger consumers are particularly drawn to the markets, showing a preference for convenient, portable health products like ready-to-drink tea bags [7] - The changing health concepts and consumption habits among the public are evident, with a shift towards personalized and immediate wellness solutions [7] Group 3: Cultural Significance - Gansu Province, as a historical center for traditional Chinese medicine, is leveraging its cultural heritage to promote health and wellness through these markets [3][5] - The initiative aims to bridge the gap between ancient medical wisdom and modern lifestyle needs, making traditional practices more relevant to contemporary society [7]

Core Insights - Guangzhou has been selected as one of the 15 cities for the national demonstration project supported by central financial funding for the inheritance and innovation of traditional Chinese medicine (TCM) [1] - The project aims to promote the inheritance and innovation of TCM techniques, talent cultivation, service models, and management system innovation, creating replicable and promotable experiences [1] Group 1: Project Objectives - The project is jointly promoted by the Ministry of Finance and the National Administration of Traditional Chinese Medicine [1] - It focuses on forming a national-level demonstration benchmark for TCM development [1] Group 2: Implementation Strategies - Guangzhou will implement three major projects for the inheritance of Lingnan TCM techniques, three specialized projects for TCM scientific research innovation, and three levels of talent team construction [1] - The city will also innovate four service models and establish five mechanisms for TCM management system innovation [1] Group 3: Expected Outcomes - The initiative aims to create a leading high ground for the inheritance and innovation of Lingnan TCM, establishing benchmarks in six areas: technical inheritance, industrial integration, talent teams, service models, mechanism reform, and cultural dissemination [1] - The goal is to develop a TCM model characterized by outstanding clinical efficacy, efficient scientific research transformation, intelligent service systems, and far-reaching cultural influence, providing a replicable example for high-quality TCM development in the Guangdong-Hong Kong-Macao Greater Bay Area [1]